Results 111 to 120 of about 163,209 (266)

Multidisciplinary Delphi Consensus on management of children with moderate-severe atopic dermatitis. [PDF]

Ital J Pediatr
Marseglia GL, Tosca MA, Miraglia Del Giudice M, Belloni Fortina A, Bonamonte D, Neri I, Peroni DG, D'Avino A, Comberiati P, Filippeschi C, Manti S, Galli E, Mori F, Caffarelli C, Licari A, Ciprandi G.   +15 more
europepmc   +1 more source

Dermatitis factitia

Indian Dermatology Online Journal, 2017
Divya Gupta, Rashmi Kumari, Devinder M Thappa   +2 more
openaire   +3 more sources

Boost Approaches in Patients Undergoing Postoperative Radiotherapy

Journal of Surgical Oncology, EarlyView.
ABSTRACT The use of breast conservation surgery for early‐stage breast cancer is common, and adjuvant radiotherapy is often recommended to reduce the risk of ipsilateral breast tumor recurrence. Historical trials have used sequential boost techniques with favorable outcomes with reduction in local recurrence and acceptable cosmetic outcomes.
Abigail Pepin, Neil D. Almeida, Simon Fung‐Kee‐Fung, Megan Kassick, Neil K. Taunk, Gary M. Freedman   +5 more
wiley   +1 more source

Reframing Eczema: Th2-Skewed Contact Sensitization, Atopy Patch Testing, and Systemic Contact Dermatitis. [PDF]

Curr Allergy Asthma Rep
Jacob SE, Scheman A, Nedorost S.
europepmc   +1 more source

Clinically Meaningful Improvements in Quality of Life, Including Sleep, With Two‐Week and Monthly Dosed Rademikibart: A Phase 2 Randomized Trial in Adults With Moderate‐to‐Severe Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
Rademikibart, a potent IL‐4Rα‐targeting antibody, achieved its primary endpoint as a treatment for adults with moderate‐to‐severe atopic dermatitis (AD) in the CBP‐201‐WW001 Phase 2 trial. There is a need for AD treatment options with convenient dosing intervals.
Jonathan I. Silverberg, Emma Guttman‐Yassky, Raúl Collazo   +2 more
wiley   +1 more source

Exhaled breath condensate thymic stromal lymphopoietin, OX40 ligand, eotaxin, and interleukin-23 in children with atopic dermatitis and persistent wheeze. [PDF]

Allergy Asthma Proc
Geyik C, Cansever M, Bektas F, Dorterler K, Saraymen B, Tahan F.   +5 more
europepmc   +1 more source

Prevalence and Burden of Somatic Symptom Disorder in Atopic Dermatitis and Chronic Pruritus—The Persistent Somatic Symptoms Across Diseases: Pruritus (SOMA.PRU) Study

JEADV Clinical Practice, EarlyView.
In adults with atopic dermatitis and chronic pruritus, the mental comorbidity of Somatic Symptom Disorder is associated with higher average and worst pruritus intensity, higher psychological distress and lower quality of life. Additionally, there were nonsignificant changes in cutaneous nerve fiber densities in skin biopsies.
Stefan M. Kahnert, Ansgar Koechel, Gina L. Frank, Svenja Royeck, Claudia Zeidler, Felix Witte, Christian Mess, Konstantin Agelopoulos, Volker Huck, Bernd Löwe, Rupert Conrad, Gudrun Schneider, Stefan W. Schneider, Sonja Ständer   +13 more
wiley   +1 more source

A Case of Pembrolizumab‐Induced Pityriasis Lichenoides‐Like Eruption Treated Successfully With Dupilumab

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou, Sharon Edwards, Andrew Affleck   +2 more
wiley   +1 more source

Dupilumab induces a significant decrease of food specific immunoglobulin E levels in pediatric atopic dermatitis patients

Clinical and Translational Allergy
Lisa P. van derRijst, Michelle S. Hilbrands, Nicolaas P. A. Zuithoff, Marjolein S. deBruin‐Weller, André C. Knulst, Thuy‐My Le, Marlies deGraaf   +6 more
doaj   +1 more source

A Complex Case of Unilateral Stasis Dermatitis With Id Reaction Misdiagnosed as Cellulitis: A Diagnostic Challenge. [PDF]

Cureus
Johnson SM, Roh YS, Rozati S.
europepmc   +1 more source